Table I.
Association between LincIN expression and the clinicopathological characteristics of patients with ESCC (n=56).
| Characteristics | Total | LincIN expression
|
P-value | |
|---|---|---|---|---|
| Low | High | |||
| Sex | 1.000 | |||
| Male | 30 | 15 | 15 | |
| Female | 26 | 13 | 13 | |
| Age (years) | 0.788 | |||
| ≤60 | 25 | 13 | 12 | |
| >60 | 31 | 15 | 16 | |
| Differentiation | 0.158 | |||
| Well or moderate | 37 | 21 | 16 | |
| Poor | 19 | 7 | 12 | |
| Tumor invasion depth (T) | 0.032 | |||
| T1/T2 | 30 | 19 | 11 | |
| T3/T4 | 26 | 9 | 17 | |
| Lymph node metastasis (N) | 0.029 | |||
| N0 | 34 | 21 | 13 | |
| N1-N3 | 22 | 7 | 15 | |
| TNM stage | 0.043 | |||
| I | 26 | 17 | 9 | |
| II | 17 | 8 | 9 | |
| III | 13 | 3 | 10 | |
P-values were calculated using Pearson's Chi-squared test. Values in bold font indicate statistically significant differences (P<0.05). ESCC, esophageal squamous cell carcinoma.